Actively Recruiting
Testing a Mammography Decision Intervention in a Rural Setting
Led by Dartmouth-Hitchcock Medical Center · Updated on 2025-09-29
39
Participants Needed
1
Research Sites
34 weeks
Total Duration
On this page
Sponsors
D
Dartmouth-Hitchcock Medical Center
Lead Sponsor
T
Trustees of Dartmouth College
Collaborating Sponsor
AI-Summary
What this Trial Is About
The overall objective of this COBRE pilot project is to enhance the design of a 3-arm cluster randomized trial that will test the efficacy and mechanism of effect of the MyMammogram DA with or without a provider communication intervention. This will be accomplished through two aims: (1) Refine, with community partner input, a clinical trial protocol to optimize engagement among patients and primary care providers (PCPs) practicing in rural settings. In consultation with patients, PCPs, and informatics experts, the study team will refine site selection, randomization, patient and PCP recruitment, and data collection protocols to meet the needs of the rural health care delivery system and participants. The result of this aim will be a modified protocol and intervention strategy that is acceptable to partners. (2) Adapt and test trial and intervention implementation features to achieve protocol acceptance and adherence. The investigators will pilot the adapted three-arm randomized trial protocol in rural primary care settings that compares the MyMammogram DA with or without a risk summary provided to the PCP pre-visit, relative to usual care. Implementing the trial in two phases (n=15 each) will systematically identify barriers and facilitators to trial participation to refine protocols. Participants will receive acceptability surveys and investigators will conduct qualitative interviews with patients and PCPs to understand experiences with trial implementation from multiple perspectives.
CONDITIONS
Official Title
Testing a Mammography Decision Intervention in a Rural Setting
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female
- Aged 39 to 49 years
- Upcoming appointment with a participating primary care provider within 4 weeks
- English or Spanish-speaking
You will not qualify if you...
- Personal history of breast cancer including lobular carcinoma in situ, ductal carcinoma in situ, or atypical hyperplasia
- Mammogram in the prior 12 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cheshire Medical Center
Keene, New Hampshire, United States, 03431
Actively Recruiting
Research Team
C
Christine M Gunn, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here